DK1953161T3 - Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse - Google Patents

Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK1953161T3
DK1953161T3 DK08290088T DK08290088T DK1953161T3 DK 1953161 T3 DK1953161 T3 DK 1953161T3 DK 08290088 T DK08290088 T DK 08290088T DK 08290088 T DK08290088 T DK 08290088T DK 1953161 T3 DK1953161 T3 DK 1953161T3
Authority
DK
Denmark
Prior art keywords
preparing
processes
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK08290088T
Other languages
English (en)
Inventor
Patrick Casara
Diguarher Thierry Le
Olivier Geneste
John Hickman
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1953161T3 publication Critical patent/DK1953161T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
DK08290088T 2007-02-02 2008-02-01 Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse DK1953161T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700741A FR2912145B1 (fr) 2007-02-02 2007-02-02 Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1953161T3 true DK1953161T3 (da) 2009-11-30

Family

ID=38219469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08290088T DK1953161T3 (da) 2007-02-02 2008-02-01 Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse

Country Status (45)

Country Link
US (1) US20080188460A1 (da)
EP (1) EP1953161B1 (da)
JP (1) JP2008266296A (da)
KR (1) KR100997027B1 (da)
CN (1) CN101270120A (da)
AP (1) AP2009004945A0 (da)
AR (1) AR065131A1 (da)
AT (1) ATE440842T1 (da)
AU (1) AU2008200499A1 (da)
BR (1) BRPI0800988A2 (da)
CA (1) CA2619897C (da)
CL (1) CL2008000318A1 (da)
CO (1) CO6230990A2 (da)
CR (1) CR10953A (da)
CY (1) CY1109637T1 (da)
DE (1) DE602008000104D1 (da)
DK (1) DK1953161T3 (da)
EA (1) EA014672B1 (da)
EC (1) ECSP099546A (da)
ES (1) ES2332337T3 (da)
FR (1) FR2912145B1 (da)
GE (1) GEP20115186B (da)
GT (1) GT200900217A (da)
HR (1) HRP20090565T1 (da)
IL (1) IL200128A0 (da)
JO (1) JO2616B1 (da)
MA (1) MA29725B1 (da)
MX (1) MX2008001504A (da)
MY (1) MY144633A (da)
NI (1) NI200900147A (da)
NZ (1) NZ565643A (da)
PA (1) PA8768301A1 (da)
PE (1) PE20081703A1 (da)
PL (1) PL1953161T3 (da)
PT (1) PT1953161E (da)
RS (1) RS51133B (da)
SA (1) SA08290043B1 (da)
SG (1) SG144892A1 (da)
SI (1) SI1953161T1 (da)
SV (1) SV2009003348A (da)
TN (1) TN2009000307A1 (da)
TW (1) TW200838532A (da)
UA (1) UA90726C2 (da)
WO (1) WO2008110691A1 (da)
ZA (1) ZA200801103B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544833B2 (en) 2006-09-07 2009-06-09 Hoffmann-La Roche Inc. Methods for producing N-(8-[2-hydroxybenzoyl]-amino) caprylic acid
FR2933983B1 (fr) * 2008-07-15 2010-08-27 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US8518933B2 (en) * 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) * 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
WO2010124042A2 (en) * 2009-04-23 2010-10-28 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
KR20120078715A (ko) * 2009-09-10 2012-07-10 노파르티스 아게 암의 치료를 위한 ｂｃｌ-2군 단백질의 억제제로서의 술폰아미드
CN102584744B (zh) * 2011-01-06 2015-07-01 上海药明康德新药开发有限公司 4-(4-((2-(4-氯苯基)-5,5-二甲基环己基-1-烯)甲基)哌嗪-1-基)苯甲酸的合成方法
US8946445B2 (en) 2011-10-12 2015-02-03 Nanjing Allgen Pharma Co., Ltd. Heterocyclic molecules as apoptosis inducers
TWI620733B (zh) 2013-05-21 2018-04-11 拜耳作物科學股份有限公司 製備特定肟類及肟醚類之改良方法
JOP20190239A1 (ar) 2017-04-19 2019-10-09 Neurocrine Biosciences Inc مركبات مثبطة لـ vmat2 وتركيبات منها

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899490A (en) * 1968-01-12 1975-08-12 Pfizer Hexahydro pyrazinoquinolines
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5688950A (en) * 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
JP2000169475A (ja) * 1998-07-24 2000-06-20 Dai Ichi Seiyaku Co Ltd ピラゾ―ル誘導体およびその塩
US6180629B1 (en) * 1998-08-14 2001-01-30 Cell Pathways, Inc. [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
US6190629B1 (en) 1999-04-16 2001-02-20 Cbl Technologies, Inc. Organic acid scrubber and methods
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
JP4180365B2 (ja) * 2000-07-31 2008-11-12 エフ．ホフマン−ラ ロシュ アーゲー ピペラジン誘導体
ES2320980T3 (es) * 2001-11-03 2009-06-01 Astrazeneca Ab Derivados de quinazolina como agentes antitumorales.
NZ533649A (en) * 2001-12-21 2006-01-27 King Pharmaceuticals Res & Dev Tyrosyl derivatives and their use as P2X7 receptor modulators
FR2841243B1 (fr) * 2002-06-19 2004-08-20 Servier Lab Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7135480B2 (en) * 2002-12-12 2006-11-14 Cytovia, Inc. Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
WO2005049593A2 (en) * 2003-11-13 2005-06-02 Abbott Laboratories N-acylsulfonamide apoptosis promoters
ES2564804T3 (es) * 2004-02-12 2016-03-29 Mitsubishi Tanabe Pharma Corporation Compuesto de indazol y uso farmacéutico del mismo
US7790712B2 (en) * 2005-03-17 2010-09-07 Boehringer Ingelheim Pharmaceutical, Inc. Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors
EP2249818A4 (en) * 2008-02-12 2011-09-07 Univ Stanford HEDGEHOG SIGNAL AWAY ANTAGONISTS AND USE METHOD

Also Published As

Publication number Publication date
SG144892A1 (en) 2008-08-28
WO2008110691A1 (fr) 2008-09-18
CO6230990A2 (es) 2010-12-20
TN2009000307A1 (fr) 2010-12-31
AR065131A1 (es) 2009-05-20
GT200900217A (es) 2011-09-14
MA29725B1 (fr) 2008-09-01
ZA200801103B (en) 2008-12-31
ECSP099546A (es) 2009-08-28
CA2619897C (fr) 2011-06-14
DE602008000104D1 (de) 2009-10-08
FR2912145B1 (fr) 2009-03-06
MY144633A (en) 2011-10-14
BRPI0800988A2 (pt) 2008-11-25
CR10953A (es) 2009-09-09
MX2008001504A (es) 2009-02-24
CN101270120A (zh) 2008-09-24
KR20080072574A (ko) 2008-08-06
RS51133B (sr) 2010-10-31
PT1953161E (pt) 2009-10-26
EA200800235A1 (ru) 2008-08-29
CA2619897A1 (fr) 2008-08-02
AP2009004945A0 (en) 2009-08-31
CL2008000318A1 (es) 2008-08-08
NI200900147A (es) 2010-02-15
JP2008266296A (ja) 2008-11-06
CY1109637T1 (el) 2014-08-13
UA90726C2 (ru) 2010-05-25
US20080188460A1 (en) 2008-08-07
EP1953161A1 (fr) 2008-08-06
TW200838532A (en) 2008-10-01
ES2332337T3 (es) 2010-02-02
PL1953161T3 (pl) 2010-01-29
ATE440842T1 (de) 2009-09-15
AU2008200499A1 (en) 2008-08-21
GEP20115186B (en) 2011-03-25
JO2616B1 (ar) 2011-11-01
SI1953161T1 (sl) 2009-12-31
EA014672B1 (ru) 2010-12-30
KR100997027B1 (ko) 2010-11-25
PA8768301A1 (es) 2008-11-19
NZ565643A (en) 2009-05-31
PE20081703A1 (es) 2009-01-14
IL200128A0 (en) 2010-04-15
HRP20090565T1 (hr) 2009-12-31
SV2009003348A (es) 2010-02-01
EP1953161B1 (fr) 2009-08-26
FR2912145A1 (fr) 2008-08-08
SA08290043B1 (ar) 2011-06-22

Similar Documents

Publication Publication Date Title
DK1953161T3 (da) Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse
DK3461503T3 (da) Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder
DK2044076T3 (da) Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden
DK3434687T3 (da) Hidtil ukendte oxyntomodulinderivater og farmaceutisk præparat til behandling af fedme omfattende samme
DK2224823T4 (da) Pulverformet carotinoidmiddel til farvning af drikkevarer
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1947037T3 (da) Indretning til at ændre forholdet mellem artikler, der transporteres, og drejning af disse artikler
DK1845978T3 (da) Substituerede pyrazolopyridiner, sammensætninger, som indeholder disse, fremgangsmåde til fremstilling heraf, og anvendelse heraf
BRPI0809366A8 (pt) polipeptídeos interligados
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2036892T3 (da) 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK2180882T3 (da) Farmaceutisk faststofsammensætning af matrix-type
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2207773T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DK2213654T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
DK1874765T3 (da) Ureaderivater, fremgangsmåder til fremstilling af disse og anvendelser deraf
DK1746097T3 (da) 1,4-dihydropyridin-kondenserede heterocykliske ringe, fremgangsmåde til fremstilling af disse, anvendelse og sammensætninger, der indeholder dem
DK2125788T3 (da) Heterocykliske forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
DK2281822T3 (da) Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
DK2038294T3 (da) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-oner) og farmaceutiske præparater, der indeholder disse
BRPI0816992A2 (pt) Derivado heterocíclico tricícloco, e, composição farmacêutica